ERBB2 and breast carcinoma: Three breast cancer subtypes displayed distinct patterns, which aligned with their known phenotypes: HER2+ breast cancer included HER2-genomic amplified samples; ER+/PR+/HER2− breast cancer included HER3 expression in a higher range; and HER2 expression was in the lower range in TNBC (Fig 5C).